Testovis (Testosterone Propionate) – Italy | box 2amp x 2ml | 50 mg/ml
Pharmacological Profile of Testovis (Testosterone Propionate)
Testovis is an authentic Italian pharmaceutical preparation containing short-acting testosterone esterified with propionic acid. Manufactured by Pharmacy Steroids and Medications, each box contains 2 ampoules of 2 ml each, dosed at 50 mg/ml (providing 100 mg per ampoule). As an injectable androgenic-anabolic steroid (AAS), Testovis delivers bioidentical testosterone straight into circulation via intramuscular injection. The propionate ester ensures rapid absorption, elevating serum testosterone levels within hours of administration and clearing swiftly, which grants athletes precise control over hormone levels and minimizes fluid retention compared to longer esters.
Athletes looking to achieve lean mass accrual, rapid power output, or maintain anabolic signaling during aggressive calorie deficits frequently choose this compound. For those seeking genuine pharmaceutical-grade preparations, sourcing authentic Testosterone Propionate ensures predictable pharmacokinetics, reduced injection discomfort, and consistent biological response without unnecessary impurities.
Technical Specifications
Clinical Application and Dosing Protocols
Due to the short half-life of the propionate ester, frequent administration is critical to avoid hormonal fluctuations. Common dosing regimens in physique transformation and athletic conditioning protocols involve alternate-day (EOD) or daily intramuscular injections.
- Beginner Protocols: 50 mg to 100 mg administered every other day (EOD) for an 8-week cycle to evaluate individual tolerance and sensitivity.
- Intermediate to Advanced Protocols: 100 mg every other day or 50 mg to 100 mg daily, typically utilized in cutting phases or lean bulk setups for 6 to 10 weeks.
- Stack Compatibility: Testovis synergizes effectively with non-aromatizing compounds such as Masteron (Drostanolone Propionate), Trenbolone Acetate, or Winstrol (Stanozolol) for competition preparation and vascularity.
Aromatization, Health Monitoring & Post-Cycle Therapy (PCT)
Because testosterone aromatizes into estradiol and 5-alpha reduces into dihydrotestosterone (DHT), users should manage potential estrogenic side effects (such as water retention and gynecomastia) and androgenic effects (including acne or accelerated male pattern baldness). An Aromatase Inhibitor (AI) such as Anastrozole should be accessible during the cycle based on routine blood work. Comprehensive Post-Cycle Therapy (PCT) utilizing SERMs (such as Tamoxifen Citrate and Clomiphene Citrate) must commence 3 to 4 days post-final injection to promptly restart endogenous gonadotropin production (LH and FSH).
Frequently Asked Questions
How often should Testovis be injected to maintain stable levels?
Due to the active half-life of 24 to 36 hours, Testovis must be administered at least every other day (EOD) or daily. Infrequent administration leads to fluctuating serum testosterone, which increases side effects like mood swings and water retention.
Why choose Testovis over longer testosterone esters like Enanthate or Cypionate?
Testovis kicks in much faster, clears the system rapidly (useful for drug-tested athletes), and causes significantly less extracellular water retention, making it the preferred choice for cutting phases and athletic performance.
When should Post-Cycle Therapy (PCT) begin after completing a Testovis cycle?
Because the propionate ester clears rapidly, PCT should typically begin 3 to 4 days after the final injection, ensuring that exogenous testosterone has cleared enough to allow endogenous pituitary signaling to resume.
this product yet